MDCXW (STOCKS)

    Medicus Pharma Ltd. Warrant

    Change: —
    Prev close: —
    Company Information
    Exchange
    XNAS
    Sector
    Industry
    CEO
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    Employees
    12
    P/E (TTM)
    P/B (TTM)
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues -$221.25K
    Operating Expenses $22.40M
    Research and Development $8.42M
    Other Operating Expenses $29.41M
    Operating Income/Loss -$22.40M
    Income/Loss From Continuing Operations After Tax -$39.38M
    Income/Loss From Continuing Operations Before Tax -$39.38M
    Net Income/Loss -$39.38M
    Net Income/Loss Attributable To Noncontrolling Interest -$314.00
    Net Income/Loss Attributable To Parent -$51.22M
    Net Income/Loss Available To Common Stockholders, Basic -$51.22M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $237.00
    Preferred Stock Dividends And Other Adjustments $237.00
    Basic Earnings Per Share -$2.69
    Diluted Earnings Per Share -$2.69
    Basic Average Shares 62,895,979
    Diluted Average Shares 62,895,979
    Assets $7.43M
    Current Assets $7.28M
    Prepaid Expenses $916.96K
    Other Current Assets $6.37M
    Noncurrent Assets $144.33K
    Liabilities $6.00M
    Current Liabilities $5.95M
    Accounts Payable $2.28M
    Wages $248.91K
    Other Current Liabilities $3.43M
    Noncurrent Liabilities $45.21K
    Equity $1.43M
    Equity Attributable To Noncontrolling Interest $101.84K
    Equity Attributable To Parent $1.33M
    Liabilities And Equity $7.43M
    Net Cash Flow From Operating Activities -$27.81M
    Net Cash Flow From Operating Activities, Continuing -$27.81M
    Net Cash Flow From Investing Activities -$2.46M
    Net Cash Flow From Investing Activities, Continuing -$2.66M
    Net Cash Flow From Financing Activities $35.01M
    Net Cash Flow From Financing Activities, Continuing $35.01M
    Exchange Gains/Losses -$198.03K
    Net Cash Flow $4.74M
    Net Cash Flow, Continuing $4.93M
    Comprehensive Income/Loss -$30.51M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest -$3.01K
    Comprehensive Income/Loss Attributable To Parent -$30.51M
    Other Comprehensive Income/Loss $8.87M